PATENT CLAIM ANALYSIS

Application Number: 16040684
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "006200"]

Abstract:
The novel insulin derivates delivers, after administration to humans, insulin as a function of the glucose concentration in the tissue.

Claim (Index 7):
The insulin derivative of  claim 1 , wherein the insulin analogue is selected from a group consisting of desB30 human insulin, A14E A22K B25H B29R desB30 human insulin, A22K desB30 human insulin, A14E B25H desB30 human insulin, A22K B25H desB30 human insulin, A22K B29R desB30 human insulin, and A14E A22K B25H desB30 human insulin.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 95.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12935438', '14126215', '13224538', '12673516', '15121206']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8538556157985503
- 35 USC 102 Novelty (BERT): 0.5803645409109343
- Combined Prediction Score: 0.8265065083097887
- Mean Citation Score: 445.473044
- Max Citation Score: 501.0652
- Similarity Product: 424.12142745733263

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test